Argenx
ARGX
#456
Rank
HK$411.18 B
Marketcap
HK$6,645
Share price
-0.10%
Change (1 day)
31.01%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): HK$68.96

According to Argenx 's latest financial reports the company's current EPS (TTM) is HK$69.27. In 2024 the company made an earnings per share (EPS) of HK$108.70 an increase over its 2023 EPS that were of -HK$40.30.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$68.96-36.56%
2024HK$108.70-369.77%
2023-HK$40.30-60.46%
2022-HK$101.9163.33%
2021-HK$62.40-40.37%
2020-HK$104.64183.47%
2019-HK$36.91123.09%
2018-HK$16.5554.93%
2017-HK$10.6814.07%
2016-HK$9.3613.05%
2015-HK$8.28-36.34%
2014-HK$13.01209.04%
2013-HK$4.21-33.99%
2012-HK$6.38185.59%
2011-HK$2.23